NLS Pharmaceutics News

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 4 21:04

424B5: Prospectus

Jul 1 20:28

EFFECT: Others

Jun 26 18:03

NLS Pharmaceutics | 424B5: Prospectus

Mar 22 22:27

NLS Pharmaceutics | EFFECT: Others

Jan 23, 2023 13:15

NLS Pharmaceutics | EFFECT: Others

Dec 16, 2022 13:15

NLS Pharmaceutics | EFFECT: Others

Jun 22, 2022 12:15

NLS Pharmaceutics | 424B5: Prospectus

Apr 15, 2022 04:48

NLS Pharmaceutics | 424B3: Prospectus

Apr 13, 2022 20:17

NLS Pharmaceutics | 424B5: Prospectus

Mar 5, 2022 05:01

NLS Pharmaceutics | EFFECT: Others

Feb 14, 2022 13:15

NLS Pharmaceutics | EFFECT: Others

Jan 7, 2022 13:15

NLS Pharmaceutics | EFFECT: Others

Nov 4, 2021 12:15

NLS Pharmaceutics | EFFECT: Others

Oct 4, 2021 12:15

NLS Pharmaceutics | EFFECT: Others

Jun 7, 2021 12:15

NLS Pharmaceutics | 424B4: Prospectus

Feb 2, 2021 00:52

NLS Pharmaceutics | EFFECT: Others

Jan 29, 2021 13:15

NLS Pharmaceutics | 8-A12B: Registration of a class of securities on a national securities exchange

Jan 28, 2021 21:30